Self-administering unregulated peptides purchased online carries significant risks
Efficacy and safety of glucagon-like peptide-1/glucagon receptor co-agonist JNJ-64565111 in individuals with type 2 diabetes mellitus and obesity: a randomized dose-ranging study
On Friday, the company announced it has acquired a U.S.-based peptide facility that will "further verticalize the company's long-term ability to deliver personalized medications." Hims & Hers will explore advances across metabolic optimization, recovery science, biological resistances, cognitive performance and preventative health through the acquisition, the company said
Tirzepatides ascent may be historicbut it is likely only the beginning
Severe symptoms (chest pain, difficulty breathing, severe nausea) require emergency care
Call your prescriber for specific guidance